Financial News
Latest News about EGRX
Recent news which mentions EGRX
Stocks That Hit 52-Week Lows On Friday
July 22, 2022
From Benzinga
Tickers
EGRX
From Motley Fool
Eagle Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know
May 04, 2022
Tickers
EGRX
From Benzinga
Tickers
EGRX
From Motley Fool
Earnings Scheduled For March 7, 2022
March 07, 2022
From Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
From Benzinga
Why Shares of Endo International Slumped 22.8% on Tuesday
March 01, 2022
From Motley Fool
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
From Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
From Benzinga
Eagle Pharmaceuticals, inc (EGRX) Q3 2021 Earnings Call Transcript
November 09, 2021
Tickers
EGRX
From Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
55 Biggest Movers From Yesterday
September 01, 2021
From Benzinga
33 Stocks Moving In Tuesday's Mid-Day Session
August 31, 2021
From Benzinga
From Benzinga
Tickers
EGRX
From Motley Fool
Eagle Pharmaceuticals In-Licenses US Rights For Emergency Hospital Product, Q2 Earnings Beat Consensus
August 09, 2021
Tickers
EGRX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
